Search results
How Roche Just Cut Top 1% Biotech Stock TG Therapeutics Down A Peg
Investor's Business Daily· 11 months agoRoche unveiled positive results Thursday for a rival to TG Therapeutics' one-hour infusion for...
Top 1% Biotech TG Therapeutics Obliterates Bullish Sales Calls — And Rockets
Investor's Business Daily· 1 year agoShares of TG Therapeutics soared Monday after the company more than doubled Wall Street's...
TG Therapeutics (TGTX) Gets FDA Nod for Multiple Sclerosis Drug
Zacks via Yahoo Finance· 1 year agoThe FDA approves TG Therapeutics' (TGTX) Briumvi (ublituximab-xiiy) for treating relapsing forms of...
Pfizer Makes Progress, but This Biotech Was Wednesday's Big Winner
Motley Fool· 1 year agoThe stock market seems bound and determined to leave investors with bad memories of 2022, with major...
Why TG Therapeutics Stock Is Crashing Today
Motley Fool· 10 months agoShares of TG Therapeutics (NASDAQ: TGTX) were crashing 50.4% lower as of 11:12 a.m. ET on Tuesday. Multiple sclerosis (MS) drug Briumvi, which launched...
Company News for Dec 30, 2022
Zacks via Yahoo Finance· 1 year agoImmunoGen, Inc.’s IMGN shares jumped 5.5% after it announced CFO Susan Altschuller would not return from her time off. Shares of TG Therapeutics, Inc....
Dow Jones Futures Fall: Tesla Runs On GM Charging Deal; Boeing, Apple Chipmaker In Buy Areas
Investor's Business Daily· 1 year agoThe market rally showed constructive action Thursday. Boeing and Apple chipmaker Taiwan...
March-ing Forward With Another New Year’s Prediction
InvestorPlace via Yahoo Finance· 3 months agoEditor’s Note: InvestorPlace offices, including Customer Service, will be offline on Friday, Mar. 29. Regular hours will resume on Monday, Apr. 1, at 9:00 a.m. Eastern time. Hello, Reader. At ...
